Valuation: Olympus Corporation

Market Cap 2,131B 13.58B 11.84B 11.18B 10.15B 19.02B 1,303B 19.1B 134B 51.67B 662B 51B 49.86B P/E 2027 *
20.3x
P/E 2028 * 17.6x
Enterprise Value 2,213B 14.1B 12.29B 11.61B 10.54B 19.75B 1,353B 19.83B 139B 53.65B 688B 52.95B 51.78B EV / Sales 2027 *
2.05x
EV / Sales 2028 * 1.96x
Free-Float
94.58%
Yield 2027 *
1.53%
Yield 2028 * 1.6%
1 day-0.94%
1 week+1.78%
Current month-4.77%
1 month-5.25%
3 months+20.13%
6 months+43.06%
Current year+1.03%
1 week 1,973
Extreme 1973
2,036
1 month 1,892
Extreme 1892
2,210.5
Current year 1,302.5
Extreme 1302.5
2,210.5
1 year 1,302.5
Extreme 1302.5
2,210.5
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%+1.78%+8.38%-1.84% 13.58B
-1.04%+6.83%+35.41%+28.31% 241B
-0.32%+5.83%+8.47%-16.53% 149B
+2.55%+6.55%-9.75%+31.91% 139B
-0.48%+0.84%-55.88%-18.23% 62.81B
+0.01%+4.61%+18.39%+21.00% 50.87B
-1.69%-1.20%-20.18%-16.57% 48.21B
+0.08%+6.49%+22.61%+38.85% 44.11B
-1.88%+3.25%+37.62%+54.22% 41.42B
-2.27%+16.07%+132.57%+68.26% 36.18B
Average -0.60%+5.96%+17.76%+18.94% 82.59B
Weighted average by Cap. -0.27%+6.06%+14.96%+17.34%

Financials

2027 *2028 *
Net sales 1,080B 6.88B 6B 5.67B 5.15B 9.64B 660B 9.68B 67.88B 26.2B 336B 25.85B 25.28B 1,122B 7.15B 6.23B 5.88B 5.34B 10.01B 686B 10.05B 70.49B 27.2B 349B 26.85B 26.25B
Net income 105B 671M 585M 553M 502M 940M 64.42B 944M 6.62B 2.56B 32.75B 2.52B 2.47B 122B 780M 680M 642M 583M 1.09B 74.85B 1.1B 7.69B 2.97B 38.05B 2.93B 2.87B
Net Debt 81.71B 521M 454M 429M 389M 729M 49.95B 732M 5.13B 1.98B 25.4B 1.96B 1.91B 64.09B 408M 356M 336M 305M 572M 39.18B 574M 4.03B 1.55B 19.92B 1.53B 1.5B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-09-18 ¥2,005.00 -0.94% 5,796,800
26-09-17 ¥2,024.00 +1.96% 2,966,100
26-09-16 ¥1,985.00 +0.51% 2,235,100
26-09-15 ¥1,975.00 -0.55% 3,037,200
26-09-14 ¥1,986.00 +0.81% 3,211,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,005.00JPY
Average target price
2,161.54JPY
Spread / Average Target
+7.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!